1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Biosimilars Market 2016-2020

Global Biosimilars Market 2016-2020

  • August 2016
  • -
  • Infiniti Research Limited
  • -
  • 152 pages

Summary

Table of Contents

Search Inside

About Biosimilars

Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.

Technavio’s analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Biocon
- Celltrion
- Dr. Reddy's Laboratories
- Hospira
- Sandoz
- STADA
- Teva Pharmaceuticals


Other prominent vendors
- 3SBio
- Accord Healthcare
- AET Biotech
- Allergan
- Alvartis Pharma
- Amega Biotech
- Amgen
- Apotex
- Aspen
- AstraZeneca
- Aurobindo Pharma
- Baxter
- Bharat Serums
- Bio Sidus
- Biogen
- Bionovis
- Bioton
- BioXpress Therapeutics
- Boehringer Ingelheim
- Boston Oncology
- Cipla
- Coherus Biosciences
- Daiichi Sankyo
- Emcure Pharmaceuticals
- Gedeon Richter
- GeneScience Pharmaceuticals
- GSK
- Hetero Drugs
- iBio
- Intas Pharmaceuticals
- JCR Pharmaceuticals
- LG Lifesciences
- Lonza
- Merck
- Mitsubishi Tanabe Pharma
- Momenta Pharmaceuticals
- Mylan
- Natco Pharma
- Novartis
- Pfenex
- Pfizer
- Ranbaxy Laboratories
- Roche Holding
- Samsung Biologics
- Sanofi
- Synthon
- Wockhardt
- Zydus Cadila Healthcare

Market driver
- Rise in number of patent expiries
- For a full, detailed list, view our report

Market challenge
- Physicians reluctance to prescribe biosimilars
- For a full, detailed list, view our report

Market trend
- Emergence of biosimilars
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.








Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Biosimilars Market, Europe, Forecast to 2025

Biosimilars Market, Europe, Forecast to 2025

  • $ 4950
  • Industry report
  • March 2017
  • by Frost & Sullivan

A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter Patent expiration and increased use of traditional generic drugs are leading to a ...

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

  • $ 4550
  • Industry report
  • January 2017
  • by Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.